In today’s briefing:
- What Will Remain with Demerged Siemens Ltd?
- Telegram from Srinagar | Operation Sindoor – On Ground Update
- Siemens Energy India Ltd: Value Unlocking, Demerger
- Panache Digilife : Forensic Analysis
- Niva Bupa Health Insurance IPO Lockup-Bunch of PE Investors Could Pare Around US$500m Worth of Stock
What Will Remain with Demerged Siemens Ltd?
- Post-Demerger, Siemens Ltd (SIEM IN) continues with Digital Industries, Smart Infrastructure, and Mobility, focusing on core segments like automation, electrification, and rail transport.
- The company is getting significant orders in each segment with strong tailwind across all segment.
- Siemens Limited’s remaining business is projected to grow at a 15% CAGR, supported by strong order backlogs and improved margins.
Telegram from Srinagar | Operation Sindoor – On Ground Update
- We interact with local business owners and our channels in Srinagar, Jammu and Kashmir with an objective to understand the current sentiment on the ground.
- Srinagar, Kashmir’s summer capital, remains strategically vital in the current conflict as a military hub and political flashpoint between India and Pakistan.
- Local business owners are hopeful that the escalating conflict and the media attention surrounding it will ease by the 10th of May.
Siemens Energy India Ltd: Value Unlocking, Demerger
- Siemens is demerging its Energy business into SEIL, focusing on energy solutions and doubling transmission capacity with a INR 3.6 billion investment over 2–3 years.
- SEIL’s energy transition initiatives drive growth, with a 29.9% YoY increase in orders. Siemens Ltd.’s Digital Industries faced headwinds but remains optimistic about turnover.
- The demerger creates two independent growth engines, with Siemens Ltd. investing ₹4 billion in Smart Infrastructure, positioning both entities for strong future growth.
Panache Digilife : Forensic Analysis
- Panache DigiLife Limited is an ICT & IoT devices design, manufacturing, distribution and services company.
- Company’s accounting policy for non-provisioning of old receivables seems to be aggressive. Poor capital allocation resulted in fragile financial health.
- Concentration risk with sales from single customer accounting for 55% of revenue to be major areas of concern.
Niva Bupa Health Insurance IPO Lockup-Bunch of PE Investors Could Pare Around US$500m Worth of Stock
- Niva Bupa Health Insurance (1226871D IN) (Niva Bupa) raised around US$260m in its India IPO in Nov 2024. The lockup on its pre-IPO investors is set to expire soon.
- Niva Bupa is a health insurance firm. Its portfolio consists of health (including retail and group), personal accident, and travel insurance.
- In this note, we will talk about the lockup dynamics, possible placement and updates since our last note.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
